• KARM
  • Contact us
  • E-Submission
ABOUT
ARTICLE TYPES
BROWSE ARTICLES
AUTHOR INFORMATION

Articles

Original Article

Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial

Yu-Ting Huang, MS1orcid, Hsin-Yeh Lee, MS2orcid, Hui-Ching Cheng, MS1orcid, Hsin-Lun Yang, MS1orcid, Ching-Hsia Hung, PhD1,2orcid, Chien-Chou Su, PhD3orcid, Yu-Tzu Chang, MD, PhD4orcid, Chien-Yao Sun, MD, MSc1,5,6orcid, Kun-Ling Tsai, PhD1,2orcid
Annals of Rehabilitation Medicine 2026;50(2):105-116.
Published online: April 15, 2026

1Institute of Allied Health Sciences, College of Medicine, National Cheng Kung University, Tainan, Taiwan

2Department of Physical Therapy, College of Medicine, National Cheng Kung University, Tainan, Taiwan

3Clinical Innovation and Research Center, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

4Department of Internal Medicine, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

5Department of Geriatrics and Gerontology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, Tainan, Taiwan

6Division of Nephrology & Hypertension, Department of Medicine, Indiana University School of Medicine, Indianapolis, IN, USA

Correspondence: Chien-Yao Sun Department of Geriatrics and Gerontology, National Cheng Kung University Hospital, College of Medicine, National Cheng Kung University, No.138, Sheng Li Road, Tainan City 704, Taiwan. Tel: +886-6-2353535 Fax: +886-6-2766175 E-mail: n045758@mail.hosp.ncku.edu.tw
Kun-Ling Tsai Department of Physical Therapy, College of Medicine, National Cheng Kung University, No.1, University Road, Tainan city, 701, Taiwan. Tel: +886-6-2353535 Fax: +886-6-2370411 E-mail: kunlingtsai@mail.ncku.edu.tw
• Received: October 24, 2025   • Revised: January 23, 2026   • Accepted: March 2, 2026

© 2026 by Korean Academy of Rehabilitation Medicine

This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial License (https://creativecommons.org/licenses/by-nc/4.0/) which permits unrestricted non-commercial use, distribution, and reproduction in any medium, provided the original work is properly cited.

  • 2,923 Views
  • 86 Download
next
  • Objective
    To compare the effects of eccentric cycling (ECC), concentric cycling (CON), and standard care (CTL) on cardiopulmonary capacity, respiratory health, and quality of life (QoL) in patients with chronic kidney disease (CKD).
  • Methods
    Thirty-one CKD patients were divided into the CTL, CON, and ECC groups. The CON and ECC groups participated in 8-week, 24-session cycling programs. Outcomes were assessed through cardiopulmonary exercise tests, respiratory function tests, and the 36-Item Short Form Survey Instrument questionnaire.
  • Results
    The ECC group achieved significant improvements in maximal oxygen uptake, while the CTL group showed a decline. For oxygen uptake efficiency slope, significant changes were observed only in the ECC group, with a group-by-time interaction effect compared to CTL. Furthermore, the ECC group demonstrated the most significant increase in diaphragm movement and a significant increase in diaphragm thickness, with comparisons indicating that ECC outperformed both CTL and CON. Regarding QoL, the ECC group exhibited significantly greater improvements in Physical Component Summary and Mental Component Summary, with statistically significant differences compared with the CTL and CON groups.
  • Conclusion
    ECC is a low-effort, high-benefit exercise modality that significantly enhances cardiopulmonary fitness, respiratory function, and QoL in patients with CKD.
Chronic kidney disease (CKD) is defined by a glomerular filtration rate (GFR) of <60 mL/min/1.73 m2, the presence of kidney damage markers, or both, persisting for at least 3 months [1]. The progression of CKD is associated with various clinical complications resulting from declining renal function, contributing to poor quality of life and increased morbidity and mortality [2,3]. As GFR declines with CKD progression, patients experience fluid retention, metabolic and endocrine disturbances, cardiovascular changes, and diastolic dysfunction. These alterations contribute to a higher prevalence of pulmonary edema and respiratory muscle dysfunction. Data from the US National Health and Nutrition Examination Survey indicate that restrictive pulmonary dysfunction affects 10% of CKD patients, while obstructive pulmonary dysfunction affects 16%, particularly in stages 1–4 [4,5].
As CKD progresses, systemic inflammation, oxidative stress, and metabolic imbalances disrupt the equilibrium between protein synthesis and degradation, impair mitochondrial function, and lead to muscle wasting and sarcopenia [6]. The weakening of skeletal muscles, including respiratory muscles, reduces gas exchange efficiency and lung function, exacerbating exercise intolerance. These changes contribute to increased fatigue, reduced physical activity, and declines in functional capacity and quality of life. A strong correlation exists between physical activity levels and mortality [7]. Patients with CKD stages 3–5 demonstrate greater sarcopenia and exercise intolerance. Therefore, individualized, progressive, and supervised exercise programs are indicated to improve exercise capacity and related clinical outcomes [8].
Regular low- to moderate-intensity physical activity has been shown to provide benefits for individuals with CKD, including improvements in aerobic and functional capacity and quality of life, without negatively affecting kidney function [9]. Furthermore, combined aerobic and resistance training has been shown to improve muscle function, increase exercise tolerance, and reduce resting systolic blood pressure in CKD patients [10]. Given the strong link between reduced maximal oxygen uptake (VO2 max) and increased mortality in CKD patients, enhancing VO2 max is a key goal of exercise interventions [11]. However, post-exercise fatigue often reduces motivation and leads to poor adherence. Addressing this issue may involve minimizing the perceived effort of physical activity [12]. Eccentric exercise, which requires less oxygen and energy than concentric exercise, offers advantages such as low energy cost, reduced motion perception, and decreased metabolic demand. The lower metabolic demand of eccentric exercise is particularly beneficial for individuals with exercise intolerance, enabling them to engage in higher-intensity training [12]. Eccentric cycling (ECC), a unique form of aerobic exercise, requires four times less cardiorespiratory energy than concentric cycling (CON), improving exercise efficiency at the same perceived exertion while reducing heart rate and oxygen uptake. ECC enhances muscle strength and promotes hypertrophy [13]. Recent discussions on ECC have focused on its application in training programs for specific populations, such as frail individuals and patients with chronic conditions. For instance, studies on patients with chronic obstructive pulmonary disease and chronic heart failure have shown that ECC improves functional capacity and muscle mass more effectively than CON [14-16].
Hypertension and an elevated risk of cardiovascular disease are common in CKD patients. While traditional aerobic exercise can raise blood pressure, increase cardiac workload, and heighten the risk of exercise-related adverse events, eccentric exercise poses lower hemodynamic demands, reducing these risks. This allows individuals with compromised cardiopulmonary function to achieve the necessary exercise intensity safely. As such, ECC may be a more suitable exercise option for CKD patients than traditional CON. However, its effectiveness in this population remains insufficiently studied in existing research.
This study aimed to compare the effects of ECC and CON on cardiopulmonary exercise capacity, respiratory function, and quality of life in patients with CKD under identical exercise intensity and duration. Additionally, it evaluated the differences between ECC, CON, and standard healthcare in this population. We hypothesize that ECC will have lower cardiopulmonary and metabolic demands than CON, allowing for a higher exercise load and significantly improving cardiopulmonary exercise capacity, respiratory functions, and quality of life.
Research design and study participants
This single-center randomized controlled trial was conducted at the National Cheng Kung University Hospital (NCKUH) in Tainan, Taiwan, between March 2022 and September 2023. It followed the CONSORT (Consolidated Standards of Reporting Trials) statement and was registered on ClinicalTrials.gov (NCT06551311). Ethical approval was obtained from the Institutional Review Board of NCKUH (approval no. A-BR-110-109). All participants provided written informed consent after a detailed explanation of the study procedures. The inclusion criteria for this study were as follows: (1) a GFR <60 mL/min/1.73 m2 with a confirmed diagnosis of CKD; (2) age between 50 and 90 years; (3) ability to comprehend and follow instructions; and (4) capability to walk independently. Exclusion criteria included (1) acute renal failure; (2) hospitalization for an acute illness within the past 3 months; (3) severe joint disease or recent lower extremity surgery; (4) severe neurological conditions; (5) severe cardiovascular disease; and (6) unconsciousness or inability to cooperate during assessments. Thirty-one CKD patients were randomly assigned to one of three groups using a computer-generated sequence with equal allocation: the control group (CTL), which received standard healthcare, the CON group, or the ECC group. The CTL group continued to receive standard medical care according to institutional guidelines, which included routine nephrology follow-up, medication management, nutritional counseling, and received no study-delivered exercise training during the 8-week intervention. They were instructed to maintain their usual physical activity and underwent the same assessments at all study time points as the exercise groups.
Baseline assessments were conducted before the initiation of the exercise training program (Time point 1). Midterm assessments were performed after 12 exercise sessions (Time point 2), post-assessments after 24 exercise sessions (Time point 3), and follow-up assessments 4 weeks after the program concluded (Time point 4). All assessments and training sessions were performed under therapist supervision.
Interventions: cycling exercise training
Participants completed an 8-week cycling exercise program using either a stationary cycle ergometer or an eccentric stationary cycle ergometer (750R; Upwards Biosystems, a recumbent eccentric exercise machine manufactured in Taiwan). Both eccentric and CON were performed on a motor-driven cycle ergometer (750R). CON used the standard concentric mode. ECC used the same ergometer set to the motor-driven eccentric mode, with the cranks driven by the motor and resisted by the participant. The cranks rotate backward, and the rider resists this motion to perform muscle actions, producing large, coordinated eccentric contractions of the knee extensors and the hip extensors and flexors while maintaining the prescribed workload. The initial workload was 50% of peak power output, adjusted to a target Borg rating of perceived exertion (RPE) of 13. This strategy aligns with CKD recommendations for moderate intensity (40%–60% VO2peak) and applies RPE monitoring to harmonize internal load and maintain tolerability and safety [17-19]. Exercise intensity was increased weekly by 5%–10% of the target power, adjusted to maintain an RPE level of 13. Each session lasted 30 minutes and was conducted three times a week for 24 sessions. Fig. 1 illustrates the outline of the current study and the time points at which outcome measurements were taken. Training power output (W) and mechanical work (kJ) were recorded each session. Weekly mean achieved power, weekly mechanical work, and cumulative work across the 8-week program were summarized and are reported in Supplementary Table S1.
Cardiopulmonary exercise testing
Cardiopulmonary exercise testing (CPET) was performed under medical supervision by trained staff in a laboratory equipped for advanced life support. CPET was conducted on an electronically braked cycle ergometer (Ultima CPX; MGC Diagnostics) using an individualized ramp protocol of 15–20 W/min at a cadence of 50–60 rpm, targeting an 8–12 minutes symptom-limited duration. Continuous 12-lead ECG and breath-by-breath gas exchange were recorded. Blood pressure was measured at 2–3 minutes intervals, pulse oximetry was monitored continuously, and Borg 6–20 ratings and symptoms were documented. Tests were terminated at the participant's request or for standard absolute or relative indications, including ischemic ST changes or angina, complex arrhythmias, abnormal blood pressure responses, severe desaturation, or ataxia/cyanosis. Maximal intensity was defined as the symptom-limited peak work rate/VO2, supported by ≥1 objective criterion: respiratory exchange ratio ≥1.10, Borg RPE ≥17/20, or heart rate ≥85%–90% of age-predicted when not rate-limited by β-blockade or devices. Procedures conformed to ATS/ACCP 2003 [19] and ACSM Guidelines 2021.
Diaphragm ultrasonography
Diaphragm mobility and thickness were evaluated using diaphragm ultrasonography. Participants were positioned in a semi-recumbent position on a 30-degree wedge. Diaphragm excursion at the dome and muscle thickness at the zone of apposition (ZOA) were measured using ultrasound. Each measurement was repeated three times, and the average value was recorded. To minimize operator-dependent variability, all measurements were conducted by a single experienced therapist. These procedures were intended to minimize operator-dependent variability and reduce random error, thereby improving the interpretability of modest absolute changes. Previous methodological reviews indicated good repeatability of diaphragmatic ultrasound when performed by experienced operators using standardized techniques [20]. In this study, all ultrasound assessments were performed by a single trained therapist, using a standardized protocol. The examiner has prior research experience involving diaphragmatic ultrasound as well.
Diaphragm excursion was measured during deep breathing. A curved probe (2–5 MHz) from the ultrasound machine (LOGIQ e; GE HealthCare) was placed between the midclavicular and anterior axillary lines below the right costal margin to visualize the diaphragm in M-mode. The displacement of the right diaphragm was recorded by noting the highest point during inhalation and the lowest point during exhalation. Diaphragm thickness was measured at the end of the inspiratory and expiratory phases of breathing, from functional residual capacity to total lung capacity. A linear probe (4–12 MHz) was positioned at the ZOA in the intercostal view between the eighth and ninth intercostal spaces. The diaphragm thickening fraction (TF) was calculated as the percentage difference between the diaphragm thickness at end-inspiration and end-expiration, relative to the thickness at end-expiration. This measurement reflects diaphragm contraction ability [20].
Respiratory muscle strength and pulmonary function test
Maximal respiratory pressures were measured during maximal voluntary inhalation and exhalation, following the guidelines of the American Thoracic Society and the European Respiratory Society. Participants were seated upright with a nose clip and used a mouthpiece connected to a pressure meter (GB60; JITTO). The procedure was repeated three times, and the highest value was used for analysis. Spirometry (microQuark; COSMED) was performed as a standard pulmonary function test (PFT) to assess air volume during forced respiratory maneuvers. Key parameters measured include forced expiratory volume in one second (FEV1), forced vital capacity (FVC), and the FEV1/FVC ratio. The participants repeated the measurements 3 times, taking the maximum value as a record as well [21].
Health-related quality of life
The 36-Item Short Form Survey Instrument (SF-36) scoring process transforms responses from 36 items into 8 domains: physical functioning, role limitations due to physical health, bodily pain, general health, vitality, social functioning, role limitations due to emotional health, and mental health. These domains are combined into two summary scores: the Physical Component Summary (PCS) and the Mental Component Summary (MCS).
Statistical analysis
The sample size was determined using G*Power software (version 3.1.0), based on a standardized large effect size with a power of 0.80 and an alpha level of 0.05, considering three groups and four measurement time points. Effect size based on a similar workload-matched eccentric versus CON trial reporting meaningful exercise capacity changes. It reported effect sizes used for planning ranging from 0.6 to 1.2 [22]. We selected the lower volume (Cohen’s f: 0.60) to remain conservative. The minimum required total sample size was 21 participants. Therefore, we enrolled 31 participants to account for anticipated withdrawal.
A total of 31 participants were enrolled in the study, of whom 22 completed follow-up assessments. Data are presented as mean±standard deviation (SD) for all variables, with a significant level of p<0.05. The Kruskal–Wallis and chi-squared tests assessed baseline differences among the three groups. Data from all randomized participants were included in the longitudinal analyses. Generalized estimating equations (GEE) were applied to analyze intragroup differences across time points 1–4 throughout the intervention. GEE was also used to evaluate intragroup effects over time and group-by-time interaction effects. At baseline, there were significant differences in body mass index (BMI) values across the three groups (Table 1). Since this could influence the calculation and interpretation of results, BMI was included as an adjustment variable when calculating the interaction effect by time group. All data analyses were performed using SPSS software (version 22.0; IBM Corp.).
Demographic and medical characteristics
Thirty-one participants were recruited in the study, with the majority being male (n=18, 58.1%) (Fig. 2). The demographic details are presented in Table 1. No significant differences in age, height, weight, or body composition were found among the three groups. There were also no significant differences in CKD stage or renal blood parameters (data not shown in Table 1). However, BMI showed substantial differences across groups. The clinical profiles of stages 3–5 CKD patients are inherently diverse, as reflected in the significant baseline BMI differences. Therefore, we adjusted for this by including BMI as a covariate in our statistical models.
ECC exercise effectively improves aerobic exercise capacity as measured by CPET, including VO2, oxygen uptake efficiency slope, and minute ventilation to carbon dioxide production
Following an 8-week exercise intervention and a 1-month follow-up, the ECC group demonstrated a significant improvement in cardiopulmonary exercise capacity compared to the CTL and CON groups. Furthermore, the group-by-time interaction analysis revealed that the ECC group showed more significant improvements in specific cardiopulmonary parameters (Supplementary Table S2). The VO2 max in the ECC group displayed a consistent upward trend across all groups, with significant intragroup variations (p<0.001, slope=0.113). A significant group-by-time interaction was observed between the ECC and CTL groups (p<0.001). VO2/HR (oxygen pulse) maximal performance was also higher in the ECC group than in the other two groups (p<0.001, slope=0.378). Furthermore, the group-by-time interaction indicated that the ECC group was more beneficial than the CTL (p<0.001) and CON (p<0.001) groups. The minute ventilation to carbon dioxide production (VE/VCO2 slope) values at the anaerobic threshold (AT) and maximal stage showed a downward trend in the ECC group, with statistically significant intragroup differences (AT stage, p<0.001, slope=-0.151; maximal stage, p<0.001, slope=-0.789). Further group-by-time interaction analysis revealed that the ECC group showed statistically significant differences compared to the CTL and CON groups. Moreover, the VE/VCO2 slope showed the greatest decline in the ECC group compared with the other groups, with significant differences from the CTL (p<0.001) and CON (p<0.001) groups. For oxygen uptake efficiency slope (OUES), the CON and ECC groups demonstrated a positive trend over time. A statistically significant improvement was observed only in the ECC group (ECC slope=0.036, p<0.001; CON slope=0.012, p=0.32). Moreover, significant group-by-time interaction was found when comparing the ECC group to the CTL group (ECC vs. CTL, p<0.001) (Fig. 3).
ECC improves respiratory functions, enhances diaphragm thickening and expiratory muscle strength
All three groups showed improvements in diaphragm excursion, with the ECC group demonstrating the most significant increase (p=0.001, slope=3.561). Regarding diaphragm thickness fraction, only the ECC group displayed a positive trend and significant intragroup differences (p=0.045, slope=14.585). The between-group analysis showed significant differences between the ECC and the other two groups (ECC vs. CTL, p<0.001) (Fig. 4). In conclusion, diaphragmatic ultrasound results indicated that the ECC group showed the greatest and most statistically significant enhancement. We recognize that diaphragm TF is relatively sensitive to operator technique and breathing pattern, and that small randomized controlled trials may show modest absolute changes with comparatively large SDs. To limit random error, we obtained three measurements for each ultrasound parameter and averaged; a single trained assessor conducted all exams using a standardized protocol. Next, we paid attention to studying respiratory muscle strength in CKD subjects, we found that the CON group showed the most significant improvement in maximal inspiratory pressure (MIP) over time (p<0.001, slope=-5.79). The ECC group had the second-largest improvement, while the CTL group showed the least improvement, with significant intragroup differences (p<0.001, slope=3.401). In addition, the CTL group experienced the most significant decline in maximal expiratory muscle strength at the end of the study, whereas the ECC group had the most minor reduction (CTL, p=0.705, slope=-8.553; ECC, p=0.229, slope=-0.0249). We, therefore, turned to studying the lung function in CKD subjects. The PFT results revealed that the ECC group outperformed the other two groups in percentage predicted FVC (p=0.001, slope=1.364). The ECC group also performed better in percentage predicted FEV1 compared to the other groups (p=0.195, slope=1.204), though no significant group-by-time interaction effect was observed. Notably, the CTL group showed the most favorable overall trend in the percentage predicted FEV1/FVC among the three groups (p<0.001, slope=1.71) (Supplementary Table S3).
ECC exercise’s impact on quality-of-life
Each group showed varying changes across the eight subitems. The ECC group demonstrated noticeable improvements in seven items, making it the most improved group overall. The ECC group demonstrated the most significant improvement in PCS and MCS scores, with statistically significant differences compared to the CTL and CON groups. For PCS, the results were as follows: ECC (p<0.001, slope=4.252), CON (p<0.001, slope=-5.371), and CTL (p<0.001, slope=3.572). For MCS, significant differences were observed between ECC and CTL (p=0.003) and between ECC and CON (p=0.01) (Supplementary Table S4).
As CKD progresses, physical activity decreases, resulting in a reduced quality of life and increased morbidity and mortality. Studies have shown that regular exercise improves cardiopulmonary, neuromuscular, and cognitive functions in CKD patients, enhancing their quality of life and lowering health risks at all stages of the disease. Despite these benefits, the adoption of exercise programs in clinical settings remains limited [23-25]. Therefore, this study aimed to create a new exercise model based on existing research to identify a more effective training strategy for CKD patients. The findings show that an 8-week ECC program significantly improved aerobic exercise capacity, pulmonary functions, and quality-of-life in individuals with stage 3–5 CKD.
Exercise has shown a significant impact on cardiorespiratory function in CKD patients [26]. A previous study indicated that exercising three times per week for 3 months significantly improved VO2 in CKD patients, with even more significant improvements in programs lasting over 6 months [10]. Our results align with these findings. Both exercise intervention groups (ECC and CON) showed significant increases in VO2 max over time. Additionally, a VO2 peak exceeding 17.5 mL/min/kg strongly predicts survival in CKD patients [27]. Although neither group reached the 17.5 mL/min/kg threshold, both surpassed the clinically significant difference of 1.5 mL/min/kg [28] when comparing the experimental endpoint to the baseline. In contrast, the CTL group showed a significant decline by the experimental endpoint, with significant group-by-time interaction effects observed between the CTL and ECC groups and the CTL and CON groups. These results indicate that exercise interventions improve VO2 max performance. Notably, the VO2 max improvement appeared greater in the CON group than in the ECC group, suggesting the need for further research into the validity of the OUES as an alternative indicator.
OUES is an objective and reproducible method for assessing cardiopulmonary function, serving as a novel indicator of cardiopulmonary functional reserve. It provides stable numerical performance throughout the CPET and reflects the relationship between oxygen uptake and minute ventilation. Combining respiratory, cardiovascular, and musculoskeletal functions into a single index, OUES may offer a more practical and safer alternative to maximal exercise testing, particularly for high-risk patients, such as those with heart failure or CKD [29-32]. A study on patients with end-stage renal disease (ESRD) undergoing hemodialysis after 20 weeks of aerobic exercise training (three times per week) showed that OUES and VO2 were significantly higher in the training group than in the CTL. Additionally, OUES was strongly correlated with changes in VO2 max (r=0.78, p<0.001) [32]. This supports the findings of our study, where the ECC group showed the most significant increase in OUES, which was significantly higher than that of the CTL group. One possible reason for the increase in OUES is a smaller rise in lactate production during exercise. Research has demonstrated that physical training reduces exercise-induced metabolic acidosis, with similar effects observed in both healthy individuals and patients with heart failure [33].
ECC involves muscles working against resistance while lengthening, unlike CON, where muscles shorten during contraction. The efficiency of eccentric contractions enables higher force production with lower energy expenditure, thereby reducing metabolic costs and minimizing lactate accumulation. Moreover, ECC results in a lower cardiopulmonary response at the same absolute power output than CON, leading to decreased blood lactate levels [34,35]. Our experimental results support these findings, demonstrating that cycling training effectively enhances the cardiopulmonary exercise capacity of patients with CKD. ECC enhances the benefits of the OUES by reducing metabolic costs and cardiopulmonary demands more than CON.
Decreased lung function and exercise tolerance in patients with CKD are closely linked to disease progression, malnutrition, anemia, a sedentary lifestyle, and muscle atrophy. Research has shown that reduced contractility in skeletal muscles may also affect respiratory muscles, leading to reduced respiratory muscle strength and worsening ventilation limitations, which further impair respiratory function [36,37]. A study involving patients undergoing hemodialysis at the ESRD stage found that, during dialysis, they completed 24 high-intensity CON exercise sessions, three times per week over 8 weeks. The training group showed better outcomes than the CTL in all respiratory-related measures, including the 6-minute walk test, maximum respiratory pressure, and PFT [36]. We found that the ECC group exhibited the best diaphragm function among the three groups, particularly in diaphragm excursion and diaphragm TF. The diaphragm TF in the ECC group showed significantly more improvement than the CTL and CON groups, highlighting a clear advantage in this measure. While the absolute improvements in diaphragm parameters were modest, the statistical robustness observed suggests that ECC provides a tangible physiological stimulus to the respiratory muscles. These small magnitude changes in ultrasound measures are common in chronic disease populations but are clinically meaningful when associated with improved functional capacity and reduced fatigue. Moreover, the ECC group demonstrated superior maximal expiratory pressure compared to the other groups, further supporting the effectiveness of this intervention. These results differ from those of previous studies, likely due to differences in the type of cycling training used in those studies. Although ECC training has improved muscle strength and functional capacity, its direct effects on respiratory muscle strength are less well-documented than inspiratory muscle training. Unlike targeted respiratory muscle training, which directly focuses on respiratory muscles, ECC primarily enhances skeletal muscle strength, functional capacity, and athletic performance. While it indirectly benefits respiratory function, it may not improve respiratory muscle strength to the same degree as specific respiratory muscle training. However, its lower cardiorespiratory demands and enhanced exercise tolerance help reduce fatigue, allowing for more sustainable exercise to maintain or improve respiratory muscle function over time [15]. Our findings support this phenomenon. Despite not directly targeting respiratory muscles, the reduced metabolic demands of eccentric exercise allow for a higher overall training volume, contributing to improvements in respiratory muscle function, as seen in enhanced diaphragm performance.
Physical activity levels in patients with CKD typically decline as the disease progresses, leading to a reduced quality of life and increased mortality [38]. A previous study showed that a 12-week renal rehabilitation program significantly improved the quality of life in CKD stages 3 and 4, as measured by the SF-36 scale [39]. Additionally, the Dialysis Outcomes and Practice Patterns Study found that higher exercise frequency was positively associated with improvements in both the MCS and PCS scores of the Kidney Disease Quality-of-Life Short Form in hemodialysis patients [40]. In our study, the ECC group showed an improvement trend in both PCS and MCS scores on the SF-36 scale. Notably, the MCS exhibited the greatest improvement among the three groups, with statistically significant differences compared to the other two groups. Further analysis revealed that, within the “Vitality” item, the ECC group experienced a significant increase, with significant differences observed both within and between groups. These findings suggest that ECC may be more effective in enhancing vitality and overall quality of life in CKD patients.
This study has several limitations. First, the sample size of our study is relatively small, which increases the risk of attrition bias. Second, baseline BMI differences persisted despite adjustment, which may affect statistical power and the generalizability of our findings to the broader CKD population. Third, the 8-week intervention and 4-week follow-up are too short to establish durability, safety, or effects on hard clinical outcomes. Finally, the narrowly defined non-dialysis CKD cohort and use of a single ergometer model constrain reproducibility and broader applicability; larger multicenter trials with longer follow-up are warranted.
In conclusion, our study is the first to investigate the impact of ECC exercise on cardiopulmonary function in patients with CKD. The results show that an 8-week ECC training program significantly improves cardiopulmonary exercise capacity, respiratory functions, and quality of life. Furthermore, ECC showed favorable changes compared with CTL and comparable improvements to CON, with between-group advantages on selected outcomes. Importantly, no adverse effects were observed during the study. These findings offer preliminary evidence supporting ECC exercise as a potential new intervention for CKD patients.

CONFLICTS OF INTEREST

No potential conflict of interest relevant to this article was reported.

FUNDING INFORMATION

This study was supported by the Ministry of Science and Technology of Taiwan (MOST-111-2628-B-006-015-MY3) and National Science and Technology Council of Taiwan (NSTC-113-2410-H-024-012-MY2) ; however, the funding agency did not participate in the study design, data collection and analysis, report writing, or the decision to submit the report for publication.

AUTHOR CONTRIBUTION

Conceptualization: Huang YT, Lee HY, Yang HL, Sun CY. Data curation: Huang YT, Cheng HC, Su CC. Resources: Huang YT, Chang YT. Validation: Huang YT, Lee HY, Hung CH, Chang YT, Sun CY. Formal analysis: Lee HY, Cheng HC, Chang YT, Sun CY. Project administration: Lee HY, Hung CH, Tsai KL. Funding acquisition: Cheng HC. Investigation: Yang HL, Hung CH, Chang YT, Tsai KL. Methodology: Yang HL. Supervision: Hung CH, Su CC, Sun CY. Software: Su CC. Visualization: Tsai KL. Writing – original draft: Huang YT, Sun CY, Tsai KL. Writing – review & editing: Tsai KL. Approval of final manuscript: all authors.

DATA AVAILABILITY STATEMENT

The data supporting this study's findings are available from the corresponding author upon reasonable request.

Supplementary materials can be found via https://doi.org/10.5535/arm.250163.

Supplementary Table S1.

Mechanical work record
arm-250163-Supplementary-Table-S1.pdf

Supplementary Table S2.

Cardiopulmonary exercise testing (CPET)
arm-250163-Supplementary-Table-S2.pdf

Supplementary Table S3.

Respiratory functions
arm-250163-Supplementary-Table-S3.pdf

Supplementary Table S4.

36-Item Short Form Survey Instrument (SF-36)
arm-250163-Supplementary-Table-S4.pdf
Fig. 1.
The schematic outline of this study and the time points of outcome measurements. RPE, rating of perceived exertion; QoL, quality of life.
arm-250163f1.jpg
Fig. 2.
CONSORT (Consolidated Standards of Reporting Trials) study flow diagram of participants in three groups.
arm-250163f2.jpg
Fig. 3.
Changes in cardiopulmonary exercise testing by groups. (A) VO2 max. (B) OUES. (C) VO2/HR max. (D) VE/VCO2 slope. Data are presented as mean±standard deviation. VO2 max, maximal oxygen uptake; OUES, oxygen uptake efficiency slopeHR, oxygen pulse; VE/VCO2, minute ventilation to carbon dioxide production; CTL, control; CON, concentric cycling; ECC, eccentric cycling; Time point 1, baseline; Time point 2, 1st month; Time point 3, 2nd month; Time point 4, one-month follow-up. *p<0.05 between group comparison with group by time interaction effect.
arm-250163f3.jpg
Fig. 4.
Changes in diaphragmatic ultrasound by groups. (A) Diaphragm excursion. (B) Diaphragm TF. Data are presented as mean±standard deviation. TF, thickness fraction; CTL, control; CON, concentric cycling; ECC, eccentric cycling; Time point 1, baseline; Time point 2, 1st month; Time point 3, 2nd month; Time point 4, one-month follow-up. *p<0.05 between group comparison with group by time interaction effect.
arm-250163f4.jpg
arm-250163f5.jpg
Table 1.
Demographic and clinical characteristics of CTL, CON, and ECC groups
Demographic data CTL group (n=10) CON group (n=10) ECC group (n=11) p-value
Age 73.40±10.30 74.50±8.95 73.18±8.77 0.923
Sex 0.958
 Male 6 6 6
 Female 4 4 5
Body composition
 Height (cm) 158.35±7.61 157.85±11.83 159.64±7.80 0.731
 Weight (kg) 57.77±8.94 67.14±17.52 66.78±13.02 0.116
 Body mass index (kg/m2) 23.00±2.65 26.61±3.59 25.97±2.94 0.028*
 Body fat 27.18±5.66 30.94±5.51 31.42±4.17 0.153
 Visceral fat 8.60±4.95 13.70±6.13 13.00±6.83 0.068
 Skeletal muscle rate (%) 29.71±4.18 27.08±3.07 27.20±2.54 0.239
 Basal metabolic rate (kcal) 1,333.70±187.76 1,461.60±324.32 1,447.73±262.37 0.558
Renal function
 BUN (mg/dL) 40.88±25.00 35.22±25.07 33.64±13.59 0.782
 Creatine (mg/dL) 3.04±2.61 2.66±2.63 2.16±1.13 0.899
 eGFR (mL/min/1.73 m2) 32.51±21.13 37.49±18.66 34.53±17.62 0.923

Values are presented as mean±standard deviation or number only.

Utilized Kruskal–Wallis to compare baseline data across the three groups.

Chi-square test was used to compare sex distribution among the three groups.

CTL, control; CON, concentric cycling; ECC, eccentric cycling; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate.

*p<0.05 intragroup comparison with time effect.

  • 1. Shahbazi F, Doosti-Irani A, Soltanian A, Poorolajal J. Global forecasting of chronic kidney disease mortality rates and numbers with the generalized additive model. BMC Nephrol 2024;25:286.
  • 2. Bello AK, Alrukhaimi M, Ashuntantang GE, Basnet S, Rotter RC, Douthat WG, et al. Complications of chronic kidney disease: current state, knowledge gaps, and strategy for action. Kidney Int Suppl (2011) 2017;7:122-9.
  • 3. Marx N, Noels H, Jankowski J, Floege J, Fliser D, Böhm M. Mechanisms of cardiovascular complications in chronic kidney disease: research focus of the Transregional Research Consortium SFB TRR219 of the University Hospital Aachen (RWTH) and the Saarland University. Clin Res Cardiol 2018;107:120-6.
  • 4. Mukai H, Ming P, Lindholm B, Heimbürger O, Barany P, Stenvinkel P, et al. Lung dysfunction and mortality in patients with chronic kidney disease. Kidney Blood Press Res 2018;43:522-35.
  • 5. Navaneethan SD, Mandayam S, Arrigain S, Rahman M, Winkelmayer WC, Schold JD. Obstructive and restrictive lung function measures and CKD: National Health and Nutrition Examination Survey (NHANES) 2007-2012. Am J Kidney Dis 2016;68:414-21.
  • 6. Carrero JJ, Stenvinkel P, Cuppari L, Ikizler TA, Kalantar-Zadeh K, Kaysen G, et al. Etiology of the protein-energy wasting syndrome in chronic kidney disease: a consensus statement from the International Society of Renal Nutrition and Metabolism (ISRNM). J Ren Nutr 2013;23:77-90.
  • 7. Wilkinson TJ, Shur NF, Smith AC. "Exercise as medicine" in chronic kidney disease. Scand J Med Sci Sports 2016;26:985-8.
  • 8. Gembillo G, Calimeri S, Tranchida V, Silipigni S, Vella D, Ferrara D, et al. Lung dysfunction and chronic kidney disease: a complex network of multiple interactions. J Pers Med 2023;13:286.
  • 9. Villanego F, Naranjo J, Vigara LA, Cazorla JM, Montero ME, García T, et al. Impact of physical exercise in patients with chronic kidney disease: sistematic review and meta-analysis. Nefrologia (Engl Ed) 2020;40:237-52.
  • 10. Heiwe S, Jacobson SH. Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev 2011;2011:CD003236.
  • 11. Patel DR, Raj VM, Torres A. Chronic kidney disease, exercise, and sports in children, adolescents, and adults. Phys Sportsmed 2009;37:11-9.
  • 12. Ansari M, Hardcastle S, Myers S, Williams AD. The health and functional benefits of eccentric versus concentric exercise training: a systematic review and meta-analysis. J Sports Sci Med 2023;22:288-309.
  • 13. Barreto RV, de Lima LCR, Borszcz FK, de Lucas RD, Denadai BS. Chronic adaptations to eccentric cycling training: a systematic review and meta-analysis. Int J Environ Res Public Health 2023;20:2861.
  • 14. Inostroza M, Valdés O, Tapia G, Núñez O, Kompen MJ, Nosaka K, et al. Effects of eccentric vs concentric cycling training on patients with moderate COPD. Eur J Appl Physiol 2022;122:489-502.
  • 15. Nickel R, Troncoso F, Flores O, Gonzalez-Bartholin R, Mackay K, Diaz O, et al. Physiological response to eccentric and concentric cycling in patients with chronic obstructive pulmonary disease. Appl Physiol Nutr Metab 2020;45:1232-7.
  • 16. Besson D, Joussain C, Gremeaux V, Morisset C, Laurent Y, Casillas JM, et al. Eccentric training in chronic heart failure: feasibility and functional effects. Results of a comparative study. Ann Phys Rehabil Med 2013;56:30-40.
  • 17. López-Torres O, Azpeitia-Martínez C, González-Gross M, Reihmane D, Guadalupe-Grau A. Multicomponent home-based training program for chronic kidney disease patients during movement restriction. Int J Environ Res Public Health 2021;18:3416.
  • 18. Arazi H, Mohabbat M, Saidie P, Falahati A, Suzuki K. Effects of different types of exercise on kidney diseases. Sports (Basel) 2022;10:42.
  • 19. American Thoracic Society; American College of Chest Physicians. ATS/ACCP Statement on cardiopulmonary exercise testing. Am J Respir Crit Care Med 2003;167:211-77.
  • 20. Santana PV, Cardenas LZ, Albuquerque ALP, Carvalho CRR, Caruso P. Diaphragmatic ultrasound: a review of its methodological aspects and clinical uses. J Bras Pneumol 2020;46:e20200064.
  • 21. Graham BL, Steenbruggen I, Miller MR, Barjaktarevic IZ, Cooper BG, Hall GL, et al. Standardization of spirometry 2019 update. An Official American Thoracic Society and European Respiratory Society technical statement. Am J Respir Crit Care Med 2019;200:e70-88.
  • 22. Peñailillo L, Valladares-Ide D, Jannas-Velas S, Flores-Opazo M, Jalón M, Mendoza L, et al. Effects of eccentric, concentric and eccentric/concentric training on muscle function and mass, functional performance, cardiometabolic health, quality of life and molecular adaptations of skeletal muscle in COPD patients: a multicentre randomised trial. BMC Pulm Med 2022;22:278.
  • 23. Nishiwaki H, Hasegawa T, Shinji M, Matsuo F, Watanabe T, Makino H, et al. Practice pattern of physician's directions of exercise restriction in patients with chronic kidney disease: results from the Chronic Kidney Disease Japan Cohort study. Clin Exp Nephrol 2018;22:1108-15.
  • 24. Wilkinson TJ, McAdams-DeMarco M, Bennett PN, Wilund K. Advances in exercise therapy in predialysis chronic kidney disease, hemodialysis, peritoneal dialysis, and kidney transplantation. Curr Opin Nephrol Hypertens 2020;29:471-9.
  • 25. Zelle DM, Klaassen G, van Adrichem E, Bakker SJ, Corpeleijn E, Navis G. Physical inactivity: a risk factor and target for intervention in renal care. Nat Rev Nephrol 2017;13:152-68.
  • 26. Andrade FP, Rezende PS, Ferreira TS, Borba GC, Müller AM, Rovedder PME. Effects of intradialytic exercise on cardiopulmonary capacity in chronic kidney disease: systematic review and meta-analysis of randomized clinical trials. Sci Rep 2019;9:18470.
  • 27. Sietsema KE, Amato A, Adler SG, Brass EP. Exercise capacity as a predictor of survival among ambulatory patients with end-stage renal disease. Kidney Int 2004;65:719-24.
  • 28. Wilkinson TJ, Watson EL, Xenophontos S, Gould DW, Smith AC. The "Minimum clinically important difference" in frequently reported objective physical function tests after a 12-week renal rehabilitation exercise intervention in nondialysis chronic kidney disease. Am J Phys Med Rehabil 2019;98:431-7.
  • 29. Hollenberg M, Tager IB. Oxygen uptake efficiency slope: an index of exercise performance and cardiopulmonary reserve requiring only submaximal exercise. J Am Coll Cardiol 2000;36:194-201.
  • 30. Tsuyuki K, Kimura Y, Chiashi K, Matsushita C, Ninomiya K, Choh K, et al. Oxygen uptake efficiency slope as monitoring tool for physical training in chronic hemodialysis patients. Ther Apher Dial 2003;7:461-7.
  • 31. Kirkman DL, Muth BJ, Stock JM, Townsend RR, Edwards DG. Cardiopulmonary exercise testing reveals subclinical abnormalities in chronic kidney disease. Eur J Prev Cardiol 2018;25:1717-24.
  • 32. Baba R, Nagashima M, Goto M, Nagano Y, Yokota M, Tauchi N, et al. Oxygen uptake efficiency slope: a new index of cardiorespiratory functional reserve derived from the relation between oxygen uptake and minute ventilation during incremental exercise. J Am Coll Cardiol 1996;28:1567-72.
  • 33. Sullivan MJ, Cobb FR. The anaerobic threshold in chronic heart failure. Relation to blood lactate, ventilatory basis, reproducibility, and response to exercise training. Circulation 1990;81:II47-58.
  • 34. Peñailillo L, Blazevich AJ, Nosaka K. Factors contributing to lower metabolic demand of eccentric compared with concentric cycling. J Appl Physiol (1985) 2017;123:884-93.
  • 35. Beaven CM, Willis SJ, Cook CJ, Holmberg HC. Physiological comparison of concentric and eccentric arm cycling in males and females. PLoS One 2014;9:e112079.
  • 36. Fernandes AO, Sens YADS, Xavier VB, Miorin LA, Alves VLDS. Functional and respiratory capacity of patients with chronic kidney disease undergoing cycle ergometer training during hemodialysis sessions: a randomized clinical trial. Int J Nephrol 2019;2019:7857824.
  • 37. Faria Rde S, Fernandes N, Lovisi JC, Reboredo Mde M, Marta MS, Pinheiro Bdo V, et al. Pulmonary function and exercise tolerance are related to disease severity in pre-dialytic patients with chronic kidney disease: a cross-sectional study. BMC Nephrol 2013;14:184.
  • 38. Hoshino J. Renal rehabilitation: exercise intervention and nutritional support in dialysis patients. Nutrients 2021;13:1444.
  • 39. Rossi AP, Burris DD, Lucas FL, Crocker GA, Wasserman JC. Effects of a renal rehabilitation exercise program in patients with CKD: a randomized, controlled trial. Clin J Am Soc Nephrol 2014;9:2052-8.
  • 40. Tentori F, Elder SJ, Thumma J, Pisoni RL, Bommer J, Fissell RB, et al. Physical exercise among participants in the Dialysis Outcomes and Practice Patterns Study (DOPPS): correlates and associated outcomes. Nephrol Dial Transplant 2010;25:3050-62.

Figure & Data

References

    Citations

    Citations to this article as recorded by  

      Download Citation

      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:

      Include:

      Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
      Ann Rehabil Med. 2026;50(2):105-116.   Published online April 15, 2026
      Download Citation
      Download a citation file in RIS format that can be imported by all major citation management software, including EndNote, ProCite, RefWorks, and Reference Manager.

      Format:
      • RIS — For EndNote, ProCite, RefWorks, and most other reference management software
      • BibTeX — For JabRef, BibDesk, and other BibTeX-specific software
      Include:
      • Citation for the content below
      Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
      Ann Rehabil Med. 2026;50(2):105-116.   Published online April 15, 2026
      Close

      Figure

      • 0
      • 1
      • 2
      • 3
      • 4
      Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
      Image Image Image Image Image
      Fig. 1. The schematic outline of this study and the time points of outcome measurements. RPE, rating of perceived exertion; QoL, quality of life.
      Fig. 2. CONSORT (Consolidated Standards of Reporting Trials) study flow diagram of participants in three groups.
      Fig. 3. Changes in cardiopulmonary exercise testing by groups. (A) VO2 max. (B) OUES. (C) VO2/HR max. (D) VE/VCO2 slope. Data are presented as mean±standard deviation. VO2 max, maximal oxygen uptake; OUES, oxygen uptake efficiency slopeHR, oxygen pulse; VE/VCO2, minute ventilation to carbon dioxide production; CTL, control; CON, concentric cycling; ECC, eccentric cycling; Time point 1, baseline; Time point 2, 1st month; Time point 3, 2nd month; Time point 4, one-month follow-up. *p<0.05 between group comparison with group by time interaction effect.
      Fig. 4. Changes in diaphragmatic ultrasound by groups. (A) Diaphragm excursion. (B) Diaphragm TF. Data are presented as mean±standard deviation. TF, thickness fraction; CTL, control; CON, concentric cycling; ECC, eccentric cycling; Time point 1, baseline; Time point 2, 1st month; Time point 3, 2nd month; Time point 4, one-month follow-up. *p<0.05 between group comparison with group by time interaction effect.
      Graphical abstract
      Eccentric Cycling Improves Cardiopulmonary Fitness, Respiratory Function, and Quality of Life in Chronic Kidney Disease: A Randomized Controlled Trial
      Demographic data CTL group (n=10) CON group (n=10) ECC group (n=11) p-value
      Age 73.40±10.30 74.50±8.95 73.18±8.77 0.923
      Sex 0.958
       Male 6 6 6
       Female 4 4 5
      Body composition
       Height (cm) 158.35±7.61 157.85±11.83 159.64±7.80 0.731
       Weight (kg) 57.77±8.94 67.14±17.52 66.78±13.02 0.116
       Body mass index (kg/m2) 23.00±2.65 26.61±3.59 25.97±2.94 0.028*
       Body fat 27.18±5.66 30.94±5.51 31.42±4.17 0.153
       Visceral fat 8.60±4.95 13.70±6.13 13.00±6.83 0.068
       Skeletal muscle rate (%) 29.71±4.18 27.08±3.07 27.20±2.54 0.239
       Basal metabolic rate (kcal) 1,333.70±187.76 1,461.60±324.32 1,447.73±262.37 0.558
      Renal function
       BUN (mg/dL) 40.88±25.00 35.22±25.07 33.64±13.59 0.782
       Creatine (mg/dL) 3.04±2.61 2.66±2.63 2.16±1.13 0.899
       eGFR (mL/min/1.73 m2) 32.51±21.13 37.49±18.66 34.53±17.62 0.923
      Table 1. Demographic and clinical characteristics of CTL, CON, and ECC groups

      Values are presented as mean±standard deviation or number only.

      Utilized Kruskal–Wallis to compare baseline data across the three groups.

      Chi-square test was used to compare sex distribution among the three groups.

      CTL, control; CON, concentric cycling; ECC, eccentric cycling; BUN, blood urea nitrogen; eGFR, estimated glomerular filtration rate.

      p<0.05 intragroup comparison with time effect.

      TOP